Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosa...
Q1 2026
May 13, 2026
FY 2025
Mar 9, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 14, 2025